LRRK2 and Parkinson disease: In all, LRRK2 mutations associated with PD are fundamentally linked to mitochondrial dysfunction and subsequent neurodegeneration, opening an avenue for investigating LRRK2–mitochondria interactions for the purpose of targeting PD patients with elevated LRRK2 kinase activity and/or deficits in mitochondrial function.